Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Biogen Idec (NQ: BIIB)
296.86 USD  +4.82 (+1.65%)
Official Closing Price  /  Updated: 4:30 PM EDT, Jun 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,271,198
Open 293.10
Bid (Size) 296.76 (100)
Ask (Size) 299.50 (100)
Prev. Close 292.04
Today's Range 292.59 - 298.44
52wk Range 249.17 - 370.57
Shares Outstanding 211,007,945
Dividend Yield N/A
Performance
YTD
-11.16%
-11.16%
1 Month
+6.91%
+6.91%
3 Month
+6.14%
+6.14%
6 Month
-9.22%
-9.22%
1 Year
+13.94%
+13.94%
Top News
More News
Why Biogen, Ionis Could Be In Trouble As Others Move Into SMA Drugs
PTC Therapeutics spiked Wednesday after an analyst suggested it and Roche could rout Biogen and Ionis Pharmaceuticals in treating spinal muscular atrophy. Read More
from Investor's Business Daily
Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018
Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing an overview of its efforts targeting acute ischemic stroke on Thursday, June 28, 2018. The live webcast will be from 8:00-9:00... Read More
from GlobeNewswire News Releases
More News
Read More
Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education
from GlobeNewswire News Releases
Sanofi, Genentech and Celgene Lead the Way in Reputation Institute’s 2018 US Pharma RepTrak®, The Largest Study on Reputation of Pharmaceutical Brands in the US
from GlobeNewswire News Releases
First Week of August 17th Options Trading For Biogen (BIIB)
category Stocks
from Market News Video
After-hours buzz: TELL, AMC & more
category Biogen Inc , Investing/Stock Market , Economics/Economy , and 14 more.
from CNBC.com News
5 Experimental New Drugs That Could Be Worth $47 Billion
category VRTX , NVS , GSK , and 3 more.
from Motley Fool
Monday Sector Laggards: Consumer Products, Healthcare
category Stocks
from Market News Video
Don't Get Too Excited About PTC Therapeutics (Yet)
category NVS , IONS , BIIB , and 2 more.
from Motley Fool
Monday's ETF with Unusual Volume: IXJ
category ETFs
from ETF Channel
Notable Monday Option Activity: FB, BIIB, GWW
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More

© Copyright FinancialContent Services, Inc.
Terms and Conditions Privacy Policy Contact Us twitter linkedin twitter

Contact Us

(888) 688-9880

Services

Financial Widgets Financial Pages Web Services Consulting Financial Calculations Stock Data for Excel Newspaper Services For Advertisers Monetization Services Content Syndication Press Release Syndication

Services by Industry

Online Media Financial Services Newspaper Investor Relations Financial Blog Corporate Intranets Digital Signage Television Android Developers iOS Developers Wire Services Radio

About Us

Overview Careers Management Team Latest News Newsletters

Support

Support Articles Report an issue